Dark circle claims are the most contested territory in eye care, and the reason is simple: under-eye darkness has at least three distinct causes – pigment, vascular pooling, and a shadow cast by volume loss at the tear trough. A topical patch can meaningfully affect only the second, and only temporarily. A label that promises to remove dark circles is making a claim about anatomy that no patch can deliver.
1. Three causes, three different claims
Pigmented darkness responds to brightening actives over months, and the honest claim is about the appearance of a more even tone. Vascular darkness responds to vasoconstriction and cooling, and the claim is about the appearance of reduced puffiness and shadow, measurable within 20 to 60 minutes. Shadowing from volume loss does not respond to any topical product. Most consumers have a mix, which is why careful copy talks about the appearance of tired-looking eyes rather than the removal of circles.
2. Wording that survives review
Acceptable in most markets: helps reduce the appearance of dark circles, brightens the under-eye area, visibly de-puffs, leaves the eye area looking fresher. Risky: eliminates dark circles, removes bags, repairs the tear trough. Likely to be reclassified in many markets without a drug or device filing: any wording that implies treatment of periorbital hyperpigmentation as a condition.
3. The evidence a claim needs
Colorimetry is the backbone: measure L and b values on the under-eye area at baseline, 20 minutes, 4 weeks and 8 weeks, under standardised lighting and no makeup. Standardised photography supports the marketing but does not replace the instrument. A consumer perception study with 30 or more participants supplies the language for the front of pack. If a claim names a time frame, the readings must be taken at that time frame – a four-week result cannot support a 20-minute promise.
4. Why patches are hard to test well
The patch itself occludes and hydrates, so part of any measured improvement comes from the format rather than the actives. That is not dishonest, but the study design has to separate the two: run an active patch against a placebo patch with the same gel and no active. Without that control, the data proves that patches work, not that your patch works, and a serious buyer will ask for the comparison.
5. Market-by-market notes
In the EU, cosmetic claims must be substantiated and the Product Information File must contain the evidence; a brightening claim is cosmetic, a depigmenting claim is generally not. In the US, cosmetic claims stay clear of drug language, and MoCRA requires safety substantiation but does not require efficacy data – though retailers increasingly do. In several Asian markets, whitening is a separate regulated category with its own functional cosmetics filing, and importing a patch labelled brightening into one of those markets may require a different registration route.
6. A claim hierarchy that works
- Front of pack: looks fresher, de-puffs, brightens – visual, immediate, low risk.
- Back of pack: caffeine and hyaluronate percentages, cooling effect, hydration duration.
- Long copy: four-week appearance of a more even tone, supported by colorimetry.
- Never: treats, cures, removes, eliminates.
7. What to hold on file
Protocol, raw data, the statistical analysis, photographs with the camera settings, and the panel composition. A brand that can produce this file within a day answers a retailer’s question in a day. The eye patch range lists the bases we can supply with supporting data, and the serum guide covers the actives behind these claims.
